| This week's sponsor is Premier Research | | | How to Neutralize the Placebo Effect
Placebo response is a natural enemy of any analgesia trial. While it can help, it can also harm. Learn more about this growing phenomenon by catching the start of our 14-part Placebo Problem blogseries. Premier Research. It's what we do. Best. |
Featured Story | | | Thursday, September 21, 2017 Chris Garabedian’s accelerator has spawned its first biotech. The startup, Landos Biopharma, has secured the support of the ex-Sarepta CEO’s Xontogeny and $10 million from Perceptive Advisors to take a LANCL2-targeted treatment for inflammatory bowel disease into the clinic. |
|
|
| This week's sponsor is Althea. | | | |
Top Stories Thursday, September 21, 2017 Right on the heels of a $28 million seed financing, Provention Bio has snapped up two inflammatory bowel disease candidates from Janssen that should make it a double clinical-stage biotech next year. Thursday, September 21, 2017 FLX Bio has picked a clinical candidate from its CCR4 antagonist program. The decision positions the Celgene-backed cancer immunotherapy biotech to move oral small molecule FLX475 into the clinic later this year. Monday, September 18, 2017 For pharma and biotech, in which data is the most valuable asset, industry analysts agree that digital transformation presents an opportunity to realize unprecedented productivity gains and competitive advantage. Thursday, September 21, 2017 The new "Vant" added to the Vivek Ramaswamy family, with its aim of improving trials with artificial intelligence, announced its new CEO this week. Thursday, September 21, 2017 Indivumed, which has a large cancer biobank, has partnered with cancer research specialist Helomics to analyze human cancer biospecimens and relevant clinical data collected from patients around the world to help advance research in personalized cancer treatments. Wednesday, September 20, 2017 When it comes to combating HIV, three virus-killing antibodies should be better than one, scientists at French pharma giant Sanofi have long believed. Now they have compelling preclinical evidence that the approach might work, not only to prevent the virus that causes AIDS in healthy people, but also to treat patients facing the risk of developing resistance to current antiretroviral treatments. Wednesday, September 20, 2017 A team of researchers at Duke University is developing a treatment for glioblastoma that's made of a modified form of poliovirus. In a new paper, they describe the process by which the virus fights malignancy. It appears to do so by activating an inflammatory process. Thursday, September 21, 2017 Pfizer is counting on a new approval for Sutent, its kidney cancer drug, but an FDA advisory panel isn’t so sure—and a disappointing committee vote this week followed another threat in the form of positive kidney cancer data for Bristol-Myers’ Opdivo-Yervoy combo. Resources Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. 2nd Strategic Partnerships for Drug Repurposing October 26-27, 2017 | Boston, MA Compliance Certificate and Training for Life Sciences Professionals October 9 -12, 2017 | Newark, NJ CBI’s MedComm 2017 Conference October 26-27, 2017 | San Francisco, CA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London 11th Digital Pharma East October 3-6, 2017 | Philadelphia, PA Don't Miss This Opportunity | Life Sciences Innovation Awards Application Deadline: Friday, October 20 at midnight EST Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 